Gliomas are a highly heterogeneous tumor, refractory to treatment and the most frequently
diagnosed primary brain tumor. Although the current WHO grading system (2016) …

Glioblastoma, the most common primary brain tumor, has few available therapies providing
significant improvement in survival. Molecular signatures associated with tumor …

Importance Clinical outcomes for glioblastoma remain poor. Treatment with immune
checkpoint blockade has shown benefits in many cancer types. To our knowledge, data from a …

With rapid advances in our understanding of cancer, there is an expanding number of
potential novel combination therapies, including novel–novel combinations. Identifying which …

Background Nearly all patients with newly diagnosed glioblastoma experience recurrence
following standard-of-care radiotherapy (RT) + temozolomide (TMZ). The purpose of the …

Background Immunotherapies have demonstrated efficacy across a diverse set of tumors
supporting further evaluation in glioblastoma. The objective of this study was to evaluate the …

β-Thalassemia is the most common hereditary disease in Iran. More than two million carriers
of β-thalassemia live in Iran. Since the Iranian population is a mixture of different ethnic …

Purpose: The primary objective was to evaluate intracranial objective response rate (iORR)
in patients receiving abemaciclib with brain or leptomeningeal metastases (LM) secondary to …

Objective To investigate the in vivo effect of an imbalance between metalloproteinases and
their inhibitors, tissue inhibitors of metalloproteinases (TIMPs), in mouse articular cartilage. …

PURPOSE Effective therapies are needed for the treatment of patients with human epidermal
growth factor receptor-2 (HER2)-positive metastatic breast cancer (MBC) with brain …